
Cefixime is a premium-grade, third-generation cephalosporin antibiotic active pharmaceutical ingredient (API) with CAS number 79350-37-1. It is widely utilized across the global pharmaceutical industry to manufacture broad-spectrum antibacterial oral suspensions, tablets, and specialized clinical-strength anti-infective formulations.
Exceptional digestibility and rapid absorption provide a major competitive advantage in the formulation of therapeutic treatments. This active pharmaceutical ingredient works by providing the essential structural mechanisms—specifically binding to penicillin-binding proteins (PBPs)—needed for effective cell wall disruption. It helps manufacturers achieve potent therapeutic profiles in anti-infective medical products without sacrificing formula stability. For instance, Cefixime is frequently used as a primary ingredient in clinical-strength antimicrobial therapies. Consequently, it improves the clinical efficacy of acute bacterial infection treatments. As a result, Zyntex ensures low heavy metal content and strict microbiological control for our supply, ensuring maximum safety during your manufacturing cycle.
Moreover, Zyntex supplies specialized micronized grades for the clinical medicine industry. This compound acts as a critical nutritional fortifier, helping to enhance the defense mechanisms of patients undergoing treatment protocols. It pushes the boundaries of medical science by offering a heat-stable active source that does not affect the final solution’s viscosity. At the same time, it serves as a crucial biomaterial in the synthesis of specialized pediatric suspensions and veterinary tablets. In short, our product serves as a dependable “structural matrix.” It supports both the vitality of the human body and the precision of biomedical engineering.
Recently, scientific interest in its application for eco-friendly biodegradable therapeutic coatings has grown. It provides a natural and potent alternative to synthetic options in specific target delivery applications. Because of this, Zyntex offers refined chemical grades designed to meet the rigorous specifications of modern sustainable pharmaceutical research. Ultimately, choosing Zyntex secures a reliable and transparent chemical supply chain. We balance core chemistry expertise with rigorous quality monitoring. To conclude, our commitment ensures your Cefixime manufacturing processes achieve the highest levels of clinical performance and purity.
This high-purity bioavailable antibiotic is essential in these four primary sectors:
Primary source for capsule and tablet medications. Thus, it provides essential support for localized infectious disease recovery.
Key clinical active for uniform oral liquid delivery. Undoubtedly, it is vital for enhancing pediatric bio-absorption rates and stability.
Used for antibiotic susceptibility testing protocols. Consequently, it is vital for high-performance microbiological science.
Acts as a wide-spectrum treatment in clinical prescription formulations. Specifically, it supports rapid patient recovery and safety management.
| Parameter | Standard Value |
|---|---|
| Product Name | Cefixime (USP/EP Pharmaceutical Grade) |
| Assay / Purity | 98.0% – 102.0% (Anhydrous Basis) |
| Appearance | White to light yellow crystalline powder |
| CAS Number | 79350-37-1 |
📝 Safety & Handling: Generally recognized as a potent antibiotic compound. May cause hypersensitivity reactions in individuals sensitive to cephalosporins. Therefore, store in a cool, dry place away from direct sunlight in an airtight container. Protect from moisture to maintain pharmaceutical potency. Use standard medical-grade PPE including dust masks, gloves, and lab protection during large-scale handling. Always consult the Safety Data Sheet (SDS) for detailed storage and handling protocols.